Table 2

Baseline clinical data

All (n=116)Genetic testing not performed (n=57)Genetic testing performed (n=59)p Value
Age, years±SD44.2±8.643.8±9.444.5±7.90.66
Women, %94.894.794.90.96
Hypertension, %35.329.840.70.22
Hyperlipidaemia, %44.845.644.10.86
Diabetes mellitus, %3.41.85.10.31
BMI, kg/m2±SD26.3±5.425.8±4.526.7±6.10.34
Active smoking, %4.35.33.40.62
Postpartum, %12.912.313.60.84
STEMI*34.224.143.90.07
NSTEMI*62.270.454.40.07
Initial LVEF, mean±SD52.5±11.353.2±10.951.9±11.80.58
SCAD events, mean±SD1.26±0.51.25±0.51.27±0.60.79
FMD, %41.442.140.70.88
FMD sites†2.5±1.42.5±1.42.5±1.41.0
Aneurysm, %6.97.06.80.96
Extracoronary dissection, %5.27.03.40.38
  • *Percentages do not add up to 100 as few individuals presented with unstable angina or ventricular fibrillation/cardiovascular arrest.

  • †Includes only those with FMD.

  • BMI, body mass index; FMD, fibromuscular dysplasia; LVEF, left ventricular ejection fraction; NSTEMI, non-ST-elevation myocardial infarction; SCAD, spontaneous coronary artery dissection; STEMI, ST-elevation myocardial infarction.